Superiority of bivalirudin over heparin anticoagulation therapy for extracorporeal membrane oxygenation? Too early to draw conclusions

Superiority of bivalirudin over heparin anticoagulation therapy for extracorporeal membrane oxygenation? Too early to draw conclusions

Background: We aimed to compare the efficacy and safety of bivalirudin versus heparin as the anticoagulant in patients undergoing extracorporeal membrane oxygenation (ECMO). Methods: We conducted a search in PubMed, Embase and the Cochrane Library for all the studies in which bivalirudin was compare...

Full description

Bibliographic Details
Main Authors: Jie Gu, Hongjie Yu, Dang Lin
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:Heliyon
Subjects:
Bivalirudin
Heparin
ECMO
Thrombotic events
Major bleeding events
Mortality
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023007375

Internet

http://www.sciencedirect.com/science/article/pii/S2405844023007375

Similar Items